I

ICON plc
D

ICLR

212.750
USD
9.05
(4.44%)
Market Closed
Volume
86,330
EPS
15
Div Yield
-
P/E
25
Market Cap
17,619,231,650
OverviewSignalsIdeasNews
Related Instruments
    C
    CRL
    -9.060
    (-4.60%)
    187.740 USD
    D
    DGX
    3.615
    (2.30%)
    160.455 USD
    I
    IART
    -0.410
    (-1.76%)
    22.870 USD
    I
    ILMN
    -7.180
    (-5.05%)
    135.110 USD
    L
    LH
    -3.029
    (-1.27%)
    235.180 USD
    P
    PKI
    1.920
    (1.57%)
    124.190 USD
    Q
    QGEN
    -0.825
    (-1.96%)
    41.275 USD
    T
    TECH
    -4.920
    (-6.79%)
    67.590 USD
    TMO
    TMO
    -19.95
    (-3.74%)
    516.18 USD
    W
    WST
    -23.50
    (-6.95%)
    314.50 USD
    More
News

Title: ICON plc

Sector: Healthcare
Industry: Diagnostics & Research
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.